| Particulars |
|
|
|
|
Company Name
| Natco Pharma Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
39.23 |
B.V. (₹) |
501.20 |
| Sales(₹ Cr.) |
3,594.60 |
NP (₹ Cr.) |
1,299.73 |
| NP Var% |
-26.00 |
Div% |
250.00 |
| CPS(₹) |
75.90 |
EPS (₹) |
66.30 |
| Traded Value(₹ Lakhs) |
328.88 |
52 Week High |
1,216.00 |
| 52 Week Low |
786.00 |
Price BSE |
800.00 |
| Price NSE |
801.00 |
Market Capital (₹ Cr.) |
15,697.36 |
| P/C Ratio |
10.50 |
P/E Ratio |
12.10 |
| Price Vs.BV |
1.60 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
596.60 |
| NP(₹ Cr.) |
74.60 |
NP Var % |
-84.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
4,119.60 |
| OPM |
54.49 |
NP |
1,838.50 |
| NP Var% |
-46.85 |
EPS |
45.47 |
| PE |
17.60 |
|
|